Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1405

1.

[177Lu]-PSMA-617 radionuclide therapy in patients with metastatic castration-resistant prostate cancer - Author's reply.

Hofman MS, Violet J, Hicks RJ, Sandhu S.

Lancet Oncol. 2018 Aug;19(8):e373. doi: 10.1016/S1470-2045(18)30534-5. No abstract available.

PMID:
30102223
2.

Annotations: A power tool for writers.

Hicks RW, Roberts MEE.

J Am Assoc Nurse Pract. 2018 Aug;30(8):421-423. doi: 10.1097/JXX.0000000000000092. No abstract available.

PMID:
30085983
3.

Outcome of patients with early-stage follicular lymphoma staged with 18F-Fluorodeoxyglucose (FDG) positron emission tomography (PET) and treated with radiotherapy alone.

Ng SP, Khor R, Bressel M, MacManus M, Seymour JF, Hicks RJ, Wirth A.

Eur J Nucl Med Mol Imaging. 2018 Aug 7. doi: 10.1007/s00259-018-4112-2. [Epub ahead of print]

PMID:
30083824
4.

Equine mesenchymal stromal cells from different tissue sources display comparable immune-related gene expression profiles in response to interferon gamma (IFN)-γ.

Cassano JM, Fortier LA, Hicks RB, Harman RM, Van de Walle GR.

Vet Immunol Immunopathol. 2018 Aug;202:25-30. doi: 10.1016/j.vetimm.2018.06.008. Epub 2018 Jun 11.

PMID:
30078595
5.

A CRISP(e)R view on kidney organoids allows generation of an induced pluripotent stem cell-derived kidney model for drug discovery.

Boreström C, Jonebring A, Guo J, Palmgren H, Cederblad L, Forslöw A, Svensson A, Söderberg M, Reznichenko A, Nyström J, Patrakka J, Hicks R, Maresca M, Valastro B, Collén A.

Kidney Int. 2018 Jul 20. pii: S0085-2538(18)30356-9. doi: 10.1016/j.kint.2018.05.003. [Epub ahead of print]

6.

Circulating cell-free miR-375 as surrogate marker of tumor burden in Merkel cell carcinoma.

Fan K, Ritter C, Nghiem P, Blom A, Verhaegen ME, Dlugosz A, Odum N, Woetmann A, Tothill RW, Hicks RJ, Sand M, Schrama D, Schadendorf D, Ugurel S, Becker JC.

Clin Cancer Res. 2018 Jul 30. pii: clincanres.1184.2018. doi: 10.1158/1078-0432.CCR-18-1184. [Epub ahead of print]

PMID:
30061360
7.

Decoding non-random mutational signatures at Cas9 targeted sites.

Taheri-Ghahfarokhi A, Taylor BJ, Nitsch R, Lundin A, Cavallo AL, Madeyski-Bengtson K, Karlsson F, Clausen M, Hicks R, Mayr LM, Bohlooly-Y M, Maresca M.

Nucleic Acids Res. 2018 Jul 19. doi: 10.1093/nar/gky653. [Epub ahead of print]

PMID:
30032200
8.

What FDG-PET response-assessment method best predicts survival after curative-intent chemoradiation in non-small cell lung cancer (NSCLC): EORTC, PERCIST, Peter Mac or Deauville criteria?

Turgeon GA, Iravani A, Akhurst T, Beaulieu A, Callahan JW, Bressel M, Cole AJ, Everitt S, Siva S, Hicks RJ, Ball DL, Mac Manus MP.

J Nucl Med. 2018 Jul 20. pii: jnumed.118.214148. doi: 10.2967/jnumed.118.214148. [Epub ahead of print]

PMID:
30030343
9.

Prenatal, Neonatal, and Early Childhood Features in Congenital Myotonic Dystrophy.

Zapata-Aldana E, Ceballos-Sáenz D, Hicks R, Campbell C.

J Neuromuscul Dis. 2018;5(3):331-340. doi: 10.3233/JND-170277.

PMID:
30010141
10.

Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.

Harausz EP, Garcia-Prats AJ, Law S, Schaaf HS, Kredo T, Seddon JA, Menzies D, Turkova A, Achar J, Amanullah F, Barry P, Becerra M, Chan ED, Chan PC, Ioana Chiotan D, Crossa A, Drobac PC, Fairlie L, Falzon D, Flood J, Gegia M, Hicks RM, Isaakidis P, Kadri SM, Kampmann B, Madhi SA, Marais E, Mariandyshev A, Méndez-Echevarría A, Moore BK, Nargiza P, Ozere I, Padayatchi N, Ur-Rehman S, Rybak N, Santiago-Garcia B, Shah NS, Sharma S, Shim TS, Skrahina A, Soriano-Arandes A, van den Boom M, van der Werf MJ, van der Werf TS, Williams B, Yablokova E, Yim JJ, Furin J, Hesseling AC; Collaborative Group for Meta-Analysis of Paediatric Individual Patient Data in MDR-TB.

PLoS Med. 2018 Jul 11;15(7):e1002591. doi: 10.1371/journal.pmed.1002591. eCollection 2018 Jul.

11.

A Few Good Men: It's Not Easy Recruiting Male Hospice Palliative Care Volunteers.

Claxton-Oldfield S, McCaffrey-Noviss W, Hicks R.

Am J Hosp Palliat Care. 2018 Jan 1:1049909118785370. doi: 10.1177/1049909118785370. [Epub ahead of print]

PMID:
29986593
12.

Deep Learning Renal Segmentation for Fully Automated Radiation Dose Estimation in Unsealed Source Therapy.

Jackson P, Hardcastle N, Dawe N, Kron T, Hofman MS, Hicks RJ.

Front Oncol. 2018 Jun 14;8:215. doi: 10.3389/fonc.2018.00215. eCollection 2018.

13.

FDG PET/CT imaging in detecting and guiding management of invasive fungal infections: a retrospective comparison to conventional CT imaging.

Douglas AP, Thursky KA, Worth LJ, Drummond E, Hogg A, Hicks RJ, Slavin MA.

Eur J Nucl Med Mol Imaging. 2018 Jun 7. doi: 10.1007/s00259-018-4062-8. [Epub ahead of print]

PMID:
29882160
14.

FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II Open-Label Study of Atezolizumab in PD-L1-Selected Patients with Non-Small-Cell Lung Cancer.

Spigel DR, Chaft JE, Gettinger S, Chao BH, Dirix L, Schmid P, Chow LQM, Hicks RJ, Leon L, Fredrickson J, Kowanetz M, Sandler A, Funke R, Rizvi NA.

J Thorac Oncol. 2018 May 15. pii: S1556-0864(18)30603-8. doi: 10.1016/j.jtho.2018.05.004. [Epub ahead of print]

PMID:
29775807
15.

Keywords matter: A critical factor in getting published work discovered.

Pearce PF, Hicks RW, Pierson CA.

J Am Assoc Nurse Pract. 2018 Apr;30(4):179-181. doi: 10.1097/JXX.0000000000000048. No abstract available.

PMID:
29757784
16.

[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study.

Hofman MS, Violet J, Hicks RJ, Ferdinandus J, Thang SP, Akhurst T, Iravani A, Kong G, Ravi Kumar A, Murphy DG, Eu P, Jackson P, Scalzo M, Williams SG, Sandhu S.

Lancet Oncol. 2018 Jun;19(6):825-833. doi: 10.1016/S1470-2045(18)30198-0. Epub 2018 May 8.

PMID:
29752180
17.

Humanizing Miniature Hearts through 4-Flow Cannulation Perfusion Decellularization and Recellularization.

Nguyen DT, O'Hara M, Graneli C, Hicks R, Miliotis T, Nyström AC, Hansson S, Davidsson P, Gan LM, Magnone MC, Althage M, Heydarkhan-Hagvall S.

Sci Rep. 2018 May 10;8(1):7458. doi: 10.1038/s41598-018-25883-x.

18.

NKX6.1 induced pluripotent stem cell reporter lines for isolation and analysis of functionally relevant neuronal and pancreas populations.

Gupta SK, Wesolowska-Andersen A, Ringgaard AK, Jaiswal H, Song L, Hastoy B, Ingvorsen C, Taheri-Ghahfarokhi A, Magnusson B, Maresca M, Jensen RR, Beer NL, Fels JJ, Grunnet LG, Thomas MK, Gloyn AL, Hicks R, McCarthy MI, Hansson M, Honoré C.

Stem Cell Res. 2018 May;29:220-231. doi: 10.1016/j.scr.2018.04.010. Epub 2018 Apr 23.

19.

A first-in-man study of 68Ga-nanocolloid PET-CT sentinel lymph node imaging in prostate cancer demonstrates aberrant lymphatic drainage pathways.

Doughton JA, Hofman MS, Eu P, Hicks RJ, Williams SG.

J Nucl Med. 2018 May 4. pii: jnumed.118.209171. doi: 10.2967/jnumed.118.209171. [Epub ahead of print]

PMID:
29728517
20.

A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocol.

Hofman MS, Murphy DG, Williams SG, Nzenza T, Herschtal A, Lourenco RA, Bailey DL, Budd R, Hicks RJ, Francis RJ, Lawrentschuk N.

BJU Int. 2018 May 3. doi: 10.1111/bju.14374. [Epub ahead of print]

PMID:
29726071
21.

An international survey on hybrid imaging: do technology advances preempt our training and education efforts?

Beyer T, Hicks R, Brun C, Antoch G, Freudenberg LS.

Cancer Imaging. 2018 Apr 26;18(1):15. doi: 10.1186/s40644-018-0148-6.

22.

Surveillance imaging with FDG-PET/CT in the post-operative follow-up of stage 3 melanoma.

Lewin J, Sayers L, Kee D, Walpole I, Sanelli A, Te Marvelde L, Herschtal A, Spillane J, Gyorki D, Speakman D, Estall V, Donahoe S, Pohl M, Pope K, Chua M, Sandhu S, McArthur GA, McCormack CJ, Henderson M, Hicks RJ, Shackleton M.

Ann Oncol. 2018 Jul 1;29(7):1569-1574. doi: 10.1093/annonc/mdy124.

PMID:
29659679
23.

Follow up results of a prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer.

Ng SP, Tan J, Osbourne G, Williams L, Bressel MAB, Hicks RJ, Lau EWF, Chu J, Ngan SYK, Leong T.

Clin Transl Radiat Oncol. 2017 Mar 7;2:76-82. doi: 10.1016/j.ctro.2017.01.008. eCollection 2017 Feb.

24.

Diagnostic challenges in a patient with an occult insulinoma:68 Ga-DOTA-exendin-4 PET/CT and 68Ga-DOTATATE PET/CT.

Bongetti E, Lee MH, Pattison DA, Hicks RJ, Norris R, Sachithanandan N, MacIsaac RJ.

Clin Case Rep. 2018 Mar 1;6(4):719-722. doi: 10.1002/ccr3.1448. eCollection 2018 Apr.

25.

Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma.

Tam CS, Anderson MA, Pott C, Agarwal R, Handunnetti S, Hicks RJ, Burbury K, Turner G, Di Iulio J, Bressel M, Westerman D, Lade S, Dreyling M, Dawson SJ, Dawson MA, Seymour JF, Roberts AW.

N Engl J Med. 2018 Mar 29;378(13):1211-1223. doi: 10.1056/NEJMoa1715519.

PMID:
29590547
26.

Small molecule inducers of ABCA1 and apoE that act through indirect activation of the LXR pathway.

Fan J, Zhao RQ, Parro C, Zhao W, Chou HY, Robert J, Deeb TZ, Raynoschek C, Barichievy S, Engkvist O, Maresca M, Hicks R, Meuller J, Moss SJ, Brandon NJ, Wood MW, Kulic I, Wellington CL.

J Lipid Res. 2018 May;59(5):830-842. doi: 10.1194/jlr.M081851. Epub 2018 Mar 21.

PMID:
29563219
27.

The Injustice of Being Judged by the Errors of Others: The Tragic Tale of the Battle for PET Reimbursement.

Hicks RJ.

J Nucl Med. 2018 Mar;59(3):418-420. doi: 10.2967/jnumed.117.206953. No abstract available.

PMID:
29497002
28.

Complementary role of MRI and positron emission tomography in diagnosing cerebral abscess in a patient with metastatic paraganglioma.

Lasocki A, Hicks RJ.

J Med Imaging Radiat Oncol. 2018 Feb 26. doi: 10.1111/1754-9485.12717. [Epub ahead of print]

PMID:
29479818
29.

Multiple red-brown macules and papules in a toddler.

Hicks R, Lam JM.

Paediatr Child Health. 2017 Mar;22(1):33-34. doi: 10.1093/pch/pxx008. Epub 2017 Mar 30. No abstract available.

30.

Human iPS-Derived Astroglia from a Stable Neural Precursor State Show Improved Functionality Compared with Conventional Astrocytic Models.

Lundin A, Delsing L, Clausen M, Ricchiuto P, Sanchez J, Sabirsh A, Ding M, Synnergren J, Zetterberg H, Brolén G, Hicks R, Herland A, Falk A.

Stem Cell Reports. 2018 Mar 13;10(3):1030-1045. doi: 10.1016/j.stemcr.2018.01.021. Epub 2018 Feb 15.

31.

Cerebrospinal Fluid Biomarkers are Differentially Related to Structural and Functional Changes in Dementia of the Alzheimer's Type.

Malpas CB, Saling MM, Velakoulis D, Desmond P, Hicks RJ, Zetterberg H, Blennow K, O'Brien TJ.

J Alzheimers Dis. 2018;62(1):417-427. doi: 10.3233/JAD-170250.

PMID:
29439322
32.

PSMA-Targeted Radionuclide Therapy and Salivary Gland Toxicity: Why Does It Matter?

Taïeb D, Foletti JM, Bardiès M, Rocchi P, Hicks RJ, Haberkorn U.

J Nucl Med. 2018 May;59(5):747-748. doi: 10.2967/jnumed.118.207993. Epub 2018 Feb 9. No abstract available.

PMID:
29439016
33.

Life is not black and white, nor just Shades of Gray.

Beyer T, Hicks RJ, Freudenberg LS.

Eur J Nucl Med Mol Imaging. 2018 May;45(5):816-821. doi: 10.1007/s00259-018-3943-1. Epub 2018 Feb 8. No abstract available.

PMID:
29423530
34.
35.

Diastereomerically Differentiated Excited State Behavior in Ruthenium(II) Hexafluoroacetylacetonate Complexes of Diphenyl Thioindigo Diimine.

Boice GN, Garakyaraghi S, Patrick BO, Sanz CA, Castellano FN, Hicks RG.

Inorg Chem. 2018 Feb 5;57(3):1386-1397. doi: 10.1021/acs.inorgchem.7b02803. Epub 2018 Jan 23.

PMID:
29360353
36.

Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and Pitfalls.

Hofman MS, Hicks RJ, Maurer T, Eiber M.

Radiographics. 2018 Jan-Feb;38(1):200-217. doi: 10.1148/rg.2018170108.

PMID:
29320333
37.

Localisation of occult extra-pancreatic insulinoma using glucagon-like peptide-1 receptor molecular imaging.

Mossman AK, Pattison DA, Hicks RJ, Hamblin PS, Yates CJ.

Intern Med J. 2018 Jan;48(1):97-98. doi: 10.1111/imj.13664. No abstract available.

PMID:
29314520
38.

Characteristics of Intimate Partner Violence Incidents and the Environments in Which They Occur: Victim Reports to Responding Law Enforcement Officers.

Campbell AM, Hicks RA, Thompson SL, Wiehe SE.

J Interpers Violence. 2017 Apr 1:886260517704230. doi: 10.1177/0886260517704230. [Epub ahead of print]

PMID:
29294722
39.

68Ga PSMA-11 PET with CT urography protocol in the initial staging and biochemical relapse of prostate cancer.

Iravani A, Hofman MS, Mulcahy T, Williams S, Murphy D, Parameswaran BK, Hicks RJ.

Cancer Imaging. 2017 Dec 21;17(1):31. doi: 10.1186/s40644-017-0133-5.

40.

Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistance.

Martin CA, Cullinane C, Kirby L, Abuhammad S, Lelliott EJ, Waldeck K, Young RJ, Brajanovski N, Cameron DP, Walker R, Sanij E, Poortinga G, Hannan RD, Pearson RB, Hicks RJ, McArthur GA, Sheppard KE.

Int J Cancer. 2018 May 15;142(10):2139-2152. doi: 10.1002/ijc.31220. Epub 2018 Jan 3.

PMID:
29243224
41.

3D-Models of Insulin-Producing β-Cells: from Primary Islet Cells to Stem Cell-Derived Islets.

Ribeiro D, Kvist AJ, Wittung-Stafshede P, Hicks R, Forslöw A.

Stem Cell Rev. 2018 Apr;14(2):177-188. doi: 10.1007/s12015-017-9783-8. Review.

PMID:
29181780
42.

Navigating Nursing Education.

Hicks RW, Patterson R.

AORN J. 2017 Dec;106(6):523-533. doi: 10.1016/j.aorn.2017.10.001.

PMID:
29173377
43.

Correction to: Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis.

Thang SP, Lung MS, Kong G, Hofman MS, Callahan J, Michael M, Hicks RJ.

Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):323. doi: 10.1007/s00259-017-3886-y.

PMID:
29152667
44.

Automated preparation of 2-[18 F]fluoropropionate labeled peptides using a flexible, multi-stage synthesis platform (iPHASE Flexlab).

Haskali MB, Roselt PD, Hicks RJ, Hutton CA.

J Labelled Comp Radiopharm. 2018 Feb;61(2):61-67. doi: 10.1002/jlcr.3580. Epub 2017 Dec 29.

PMID:
29143364
45.

New Challenges in Nuclear Endocrinology.

Taïeb D, Hicks RJ, Pacak K.

J Nucl Med. 2018 Apr;59(4):573-574. doi: 10.2967/jnumed.117.199729. Epub 2017 Nov 9. No abstract available.

PMID:
29123009
46.

Human pancreatic islet-derived extracellular vesicles modulate insulin expression in 3D-differentiating iPSC clusters.

Ribeiro D, Andersson EM, Heath N, Persson-Kry A, Collins R, Hicks R, Dekker N, Forslöw A.

PLoS One. 2017 Nov 8;12(11):e0187665. doi: 10.1371/journal.pone.0187665. eCollection 2017.

47.

Frontal alpha asymmetry and aerobic exercise: are changes due to cardiovascular demand or bilateral rhythmic movement?

Hicks RA, Hall PA, Staines WR, McIlroy WE.

Biol Psychol. 2018 Feb;132:9-16. doi: 10.1016/j.biopsycho.2017.10.011. Epub 2017 Nov 2.

PMID:
29102708
48.

A Protocol-Based Approach to Spinal Epidural Abscess Imaging Improves Performance and Facilitates Early Diagnosis.

Madhuripan N, Hicks RJ, Feldmann E, Rathlev NK, Salvador D, Artenstein AW.

J Am Coll Radiol. 2018 Apr;15(4):648-651. doi: 10.1016/j.jacr.2017.09.041. Epub 2017 Nov 1. No abstract available.

PMID:
29102538
49.

Prospective Study of Serial Imaging Comparing Fluorodeoxyglucose Positron Emission Tomography (PET) and Fluorothymidine PET During Radical Chemoradiation for Non-Small Cell Lung Cancer: Reduction of Detectable Proliferation Associated With Worse Survival.

Everitt S, Ball D, Hicks RJ, Callahan J, Plumridge N, Trinh J, Herschtal A, Kron T, Mac Manus M.

Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):947-955. doi: 10.1016/j.ijrobp.2017.07.035. Epub 2017 Jul 29.

PMID:
29063854
50.

18F-FDG-Avid Thyroid Incidentalomas: The Importance of Contextual Interpretation.

Pattison DA, Bozin M, Gorelik A, Hofman MS, Hicks RJ, Skandarajah A.

J Nucl Med. 2018 May;59(5):749-755. doi: 10.2967/jnumed.117.198085. Epub 2017 Oct 12.

PMID:
29025986

Supplemental Content

Support Center